How Sleep Loss May Disrupt Brain Wiring: A Critical Look at New Myelin Research and What It Could Mean for Sleep Apnea Sufferers

Dr. Chelsie Rohrscheib, Ph.D.

Click here to download full article. 

A newly published study in the Proceedings of the National Academy of Sciences offers a compelling biological explanation for why chronic sleep loss impairs cognition, attention, and motor performance [1]. Rather than focusing solely on neurons, the researchers demonstrate that insufficient sleep directly disrupts myelin, the insulating material that allows brain signals to travel quickly and efficiently, by altering cholesterol metabolism within oligodendrocytes, the cells responsible for maintaining myelin. 

This work goes beyond the familiar narrative that “sleep deprivation makes you tired.” Instead, it identifies a cellular pathway linking sleep loss to changes in white matter integrity, slowed neural communication, and measurable behavioral deficits. While the findings are striking, they also raise important questions about how laboratory sleep deprivation translates to real-world sleep disorders such as obstructive sleep apnea (OSA).

To understand why this matters, it helps to first understand what myelin does.

Myelin is a fatty, cholesterol-rich sheath that wraps around nerve fibers, functioning much like insulation around electrical wiring. It allows electrical impulses to propagate rapidly through the brain via a process called saltatory conduction. Healthy myelin is essential for efficient communication between brain regions and supports cognitive processing speed, memory, attention, and motor coordination. Even subtle changes in myelin thickness or composition can slow signal transmission and disrupt synchronization across neural networks [2].

In this study, Simayi and colleagues used a multi-layered experimental approach combining human MRI data with extensive animal experiments. In humans, poorer sleep quality was associated with reduced white matter microstructural integrity. In rodents, the team induced prolonged sleep restriction and then assessed brain structure, electrophysiology, molecular pathways, and behavior.

After sleep restriction, animals showed thinner myelin sheaths, reduced expression of myelin basic protein, increased conduction delays between hemispheres, impaired interhemispheric synchronization, and poorer performance on cognitive and motor tasks. At the cellular level, oligodendrocytes exhibited signs of endoplasmic reticulum stress and widespread disruption of lipid metabolism, particularly cholesterol homeostasis. Direct biochemical analysis confirmed that sleep loss significantly reduced cholesterol levels within myelin membranes, increasing membrane fluidity and compromising myelin’s insulating properties.

Importantly, the researchers demonstrated functional consequences of these structural changes. Neural signals traveled more slowly across the corpus callosum, EEG synchronization between hemispheres declined, and animals performed worse on memory and motor coordination tests. These effects were not merely theoretical, they translated into observable behavioral impairment.

Perhaps most strikingly, many of these deficits could be prevented. When the animals were treated with cyclodextrin, a compound that facilitates cholesterol redistribution to myelin, cholesterol levels were restored, conduction delays normalized, and behavioral performance improved. This intervention strongly supports the authors’ central hypothesis: disrupted cholesterol handling in oligodendrocytes is a key driver of sleep-loss–related myelin dysfunction.

Several aspects of this study are particularly promising. First, it provides a coherent biological mechanism linking sleep deprivation to impaired brain function: sleep loss induces oligodendrocyte stress, disrupts cholesterol transport, compromises myelin integrity, slows neural signaling, and ultimately degrades cognitive and motor performance. Second, the investigators did not stop at molecular or imaging markers, they demonstrated real functional outcomes. Finally, the partial reversibility of these effects suggests that myelin dysfunction may be modifiable, opening the door to future therapeutic exploration.

At the same time, important limitations deserve careful consideration. The animal model involved severe and prolonged sleep restriction, far exceeding the sleep disruption experienced by most humans. While this design is useful for uncovering biological mechanisms, it limits direct translation to everyday insomnia or typical clinical sleep disorders. Most experiments were conducted in male animals, reducing generalizability across sexes. Although the authors attempted to control for stress, sleep deprivation is inherently stressful, and stress-related effects cannot be fully excluded. Finally, while human imaging data showed associations between sleep quality and white matter integrity, the detailed cholesterol–myelin pathway was demonstrated primarily in rodents.

Despite these caveats, the implications for sleep medicine are significant, particularly when considering obstructive sleep apnea.

OSA is characterized not only by fragmented sleep but also by repeated cortical arousals, intermittent hypoxia, and chronic sympathetic activation. Over time, these factors create sustained neural stress. Clinically, untreated OSA is associated with slowed cognition, impaired attention, executive dysfunction, and mood disturbances. Traditionally, these symptoms have been attributed to sleep fragmentation and oxygen deprivation [3].

This new research suggests an additional layer: chronic sleep disruption itself may impair myelin integrity and slow neural signal propagation. If similar oligodendrocyte and cholesterol-related mechanisms occur in humans with OSA, this could help explain why cognitive symptoms sometimes persist even after breathing metrics improve, and why recovery is often gradual rather than immediate following effective treatment.

Myelin remodeling is not instantaneous. Just as the brain adapts slowly to chronic sleep loss, it may take weeks or months for neural insulation and network synchronization to normalize once restorative sleep is re-established. This aligns closely with clinical experience, where patients frequently report progressive improvement in clarity, energy, and sleep quality over time rather than overnight resolution [2].

More broadly, this study reframes sleep as essential not only for synaptic health but also for maintaining the structural integrity of brain communication pathways. It reinforces a growing understanding in neuroscience: sleep is a biological maintenance state. When sleep is disrupted, whether by deprivation, insomnia, or sleep apnea, the consequences extend well beyond fatigue.

While further human research is needed, these findings provide a powerful framework for understanding how chronic sleep disruption can lead to measurable changes in brain function. They also underscore why consistent, high-quality sleep is foundational to long-term neurologic health.

Reference:

1. Simayi R, Ficiarà E, Faniyan O, Cerdán Cerdá A, Aboufares El Alaoui A, Fiorini R, Cutignano A, Piscitelli F, Maroto AS, Santos A, Del Gallo F, de Vivo L, De Santis S, Bellesi M. Sleep loss induces cholesterol-associated myelin dysfunction. Proc Natl Acad Sci U S A. 2026 Jan 27;123(4):e2523438123. doi: 10.1073/pnas.2523438123. 
2. Osso LA, Hughes EG. Dynamics of mature myelin. Nat Neurosci. 2024 Aug;27(8):1449-1461. doi: 10.1038/s41593-024-01642-2. Epub 2024 May 21. Erratum in: Nat Neurosci. 2025 Oct;28(10):2166. doi: 10.1038/s41593-025-02061-7. 
3. Zitting KM, Lockyer BJ, Azarbarzin A, Sands SA, Wang W, Wellman A, Quan SF. Association of cortical arousals with sleep-disordered breathing events. J Clin Sleep Med. 2023 May 1;19(5):899-912. doi: 10.5664/jcsm.10492.